Biotech Dealbook

biotech dealbook provides investors, analysts, scientists, and business development executives with key information and insight on biopharmaceutical company deals. we cover venture capital investment, m&a's, partnerships, licensing deals and ipo’s. the value of our deal reports is in translating the technical science and biopharmaceutical aspects of each deal. our analysts conduct in depth primary and secondary research on each transaction and combine this information with company financial information, resulting in expertly curated micro-reports. our coverage of companies and new therapies helps you keep up-to-date with key markets, identify opportunities from emerging trends, and devise strategies for investment and r&d with confidence.